References

Antisense technology: an overview and prospectus

10.1038/s41573-021-00162-z · 2021 · External reference

The chemical evolution of oligonucleotide therapies of clinical utility

10.1038/nbt.3765 · 2017 · External reference

The current landscape of nucleic acid therapeutics

2021 · External reference

Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs

10.1093/nar/gkx1239 · 2018 · External reference

Advances in analysis of therapeutic oligonucleotides with chromatography coupled to mass spectrometry

10.1021/acs.analchem.5c06656 · 2026 · External reference

Guideline on the development and manufacture of oligonucleotides

2024 · External reference

Phosphorothioates, essential components of therapeutic oligonucleotides

10.1089/nat.2014.0506 · 2014 · External reference

Impurities in oligonucleotide drug substances and drug products

10.1089/nat.2017.0691 · 2017 · External reference

10.1002/mas.21615

10.1002/mas.21615 · 2021 · External reference

31P NMR study of the desulfurization of oligonucleoside phosphorothioates effected by "aged" trichloroacetic acid solutions

10.1021/jo050035n · 2005 · External reference

THF peroxide as a factor in generating desulphurised products from the solid-phase synthesis of phosphorothioate-modified oligonucleotides

10.1039/d4ra03592e · 2024 · External reference

Separation of phosphorothioate oligonucleotide impurities by WAX HPLC under high organic content elution conditions

10.1016/j.ab.2022.114956 · 2022 · External reference

Comparing ion-pairing reagents and counter anions for ion-pair reversed-phase liquid chromatography/electrospray ionization mass spectrometry analysis of synthetic oligonucleotides

10.1002/rcm.7409 · 2015 · External reference

Characterization of therapeutic oligonucleotides by liquid chromatography

10.1016/j.jpba.2020.113105 · 2020 · External reference

The role of fluorinated alcohols as mobile phase modifiers for LC-MS analysis of oligonucleotides

10.1007/s13361-016-1500-3 · 2017 · External reference

The critical role of mobile phase pH in the performance of oligonucleotide ion-pair liquid chromatography-mass spectrometry methods

10.2144/fsoa-2021-0084 · 2021 · External reference

Impact of ion-pairing systems choice on diastereomeric selectivity of phosphorothioated oligonucleotides in reversed-phase liquid chromatography

2024 · External reference

Selectivity limits of and opportunities for ion pair chromatographic separation of oligonucleotides

2021 · External reference

Oligonucleotide analysis by hydrophilic interaction liquid chromatography-mass spectrometry in the absence of ion-pair reagents

10.1016/j.chroma.2019.02.016 · 2019 · External reference

Ion-pair reversed-phase and hydrophilic interaction chromatography methods for analysis of phosphorothioate oligonucleotides

2023 · External reference

pH effects on the separation of oligonucleotides by ion-pair reserved phase liquid chromatography mass spectrometry

2026 · External reference

Improving the chromatographic separation of phosphorothioate oligonucleotide from impurities by optimizing selectivity through mobile-phase conditions in Ion-pair reversed-phase high-performance liquid chromatography

2025 · External reference

Phosphorothioate oligonucleotides separation in ion-pairing reversed-phase liquid chromatography: Effect of ion-pairing system

2022 · External reference

Effect of ion-pairing reagent hydrophobicity on liquid chromatography and mass spectrometry analysis of oligonucleotides

2022 · External reference

Investigation of factors influencing the separation of diastereomers of phosphorothioated oligonucleotides

10.1007/s00216-019-01813-2 · 2019 · External reference